Table 1 Baseline characteristics of SLE patients and healthy controls (HC) in this study

Age, year, mean ±SD

30.84±9.48

29.83±9.72

0.474

Female/Male

56/4

21/2

>0.99

Duration, months, mean ±SD

65.15±58.65

-

-

Medications

-

-

 Prednisone dose, mg/day, median (range)

13.5 (0, 50)

-

-

 Hydroxychloroquine

57 (95)

-

-

 Cyclophosphamide

4 (6.67)

-

-

 Azathioprine

5 (8.33)

-

-

 Cyclosporine

5 (8.33)

-

-

 Mycophenolate Mofetil

17 (28.33)

-

-

 Tacrolimus

2 (3.33)

-

-

 Leflunomide

4 (6.67)

-

-

 Thalidomide

1 (1.67)

-

-

 Methotrexate

1 (1.67)

-

-

 Interleukin-2

30 (50)

-

-